Insights

Strong Patient Network SubjectWell boasts a comprehensive patient network of over 13 million individuals across 102 countries, providing an expansive base for recruitment that can be leveraged to attract sponsors seeking diverse and rapid enrollment solutions.

Recent Strategic Expansions The acquisition of Trials24 and recent hires in leadership positions such as CTO and CFO indicate a focus on technological advancement and financial growth, presenting opportunities to partner with a forward-looking company investing in innovative patient engagement solutions.

Innovative Technology Platform With a robust technology stack including analytics, digital media, and patient engagement portals like OneView, SubjectWell offers integrated digital solutions that can complement or enhance clinical trial recruitment strategies for pharmaceutical and CRO clients.

Market Position and Revenue Operating within the $10M to $50M revenue range with a solid funding base of $35M positions SubjectWell as a promising partner for companies seeking to scale patient recruitment efforts in a competitive landscape.

Focus on Compliance and Legal The appointment of a Vice President of Legal and Compliance highlights a strong emphasis on regulatory adherence and data security, which is critical for partnerships in clinical research and patient data management, ensuring reliable and compliant collaboration opportunities.

SubjectWell Tech Stack

SubjectWell uses 8 technology products and services including Teradata Analytics Platform, Google Ads, Linkedin Insight Tag, and more. Explore SubjectWell's tech stack below.

  • Teradata Analytics Platform
    Advanced Analytics And Data Science
  • Google Ads
    Advertising
  • Linkedin Insight Tag
    Analytics
  • Pentaho
    Business Intelligence
  • WordPress
    Content Management System
  • Salesforce
    Customer Relationship Management
  • Elementor
    Page Builders
  • Ruby
    Programming Languages

Media & News

SubjectWell's Email Address Formats

SubjectWell uses at least 1 format(s):
SubjectWell Email FormatsExamplePercentage
First.Last@subjectwell.comJohn.Doe@subjectwell.com
58%
First@subjectwell.comJohn@subjectwell.com
21%
Last@subjectwell.comDoe@subjectwell.com
16%
FLast@subjectwell.comJDoe@subjectwell.com
5%

Frequently Asked Questions

Where is SubjectWell's headquarters located?

Minus sign iconPlus sign icon
SubjectWell's main headquarters is located at 8300 N MoPac Expy, Ste. 300, Austin, Texas 78759, US. The company has employees across 3 continents, including AfricaNorth AmericaEurope.

What is SubjectWell's phone number?

Minus sign iconPlus sign icon
You can contact SubjectWell's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is SubjectWell's official website and social media links?

Minus sign iconPlus sign icon
SubjectWell's official website is subjectwell.com and has social profiles on LinkedInCrunchbase.

What is SubjectWell's SIC code NAICS code?

Minus sign iconPlus sign icon
SubjectWell's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SubjectWell have currently?

Minus sign iconPlus sign icon
As of October 2025, SubjectWell has approximately 187 employees across 3 continents, including AfricaNorth AmericaEurope. Key team members include Chief Executive Officer: F. M.Chief Commercial Officer (cco): J. E.Chief Financial Officer: K. S.. Explore SubjectWell's employee directory with LeadIQ.

What industry does SubjectWell belong to?

Minus sign iconPlus sign icon
SubjectWell operates in the Pharmaceutical Manufacturing industry.

What technology does SubjectWell use?

Minus sign iconPlus sign icon
SubjectWell's tech stack includes Teradata Analytics PlatformGoogle AdsLinkedin Insight TagPentahoWordPressSalesforceElementorRuby.

What is SubjectWell's email format?

Minus sign iconPlus sign icon
SubjectWell's email format typically follows the pattern of First.Last@subjectwell.com. Find more SubjectWell email formats with LeadIQ.

How much funding has SubjectWell raised to date?

Minus sign iconPlus sign icon
As of October 2025, SubjectWell has raised $35M in funding. The last funding round occurred on Oct 18, 2022 for $35M.

When was SubjectWell founded?

Minus sign iconPlus sign icon
SubjectWell was founded in 2012.
SubjectWell

SubjectWell

Pharmaceutical ManufacturingUnited States51-200 Employees

SubjectWell drives sponsors, CROs, sites, and site networks to disrupt patient recruitment and commercial development. With the most comprehensive and patient-centric technology platform driven by a growing Patient Network of 13 million+ patients, clinically trained, multilingual patient and site companions, recruiting capabilities across 102 countries, the most extensive digital media network, and services proven to reduce site burden, SubjectWell offers solutions to the greatest challenges in patient recruitment and commercial development.

Section iconCompany Overview

Headquarters
8300 N MoPac Expy, Ste. 300, Austin, Texas 78759, US
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $35M

    SubjectWell has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Oct 18, 2022 in the amount of $35M.

  • $25M$50M

    SubjectWell's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $35M

    SubjectWell has raised a total of $35M of funding over 6 rounds. Their latest funding round was raised on Oct 18, 2022 in the amount of $35M.

  • $25M$50M

    SubjectWell's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.